Search details
1.
Mucosal melanomas of different anatomic sites share a common global DNA methylation profile with cutaneous melanoma but show location-dependent patterns of genetic and epigenetic alterations.
J Pathol
; 256(1): 61-70, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34564861
2.
[What's new liquid biopsy-PIK3CA testing in breast cancer]. / What's New Liquid Biopsy PIK3CA-Testung beim Mammakarzinom.
Pathologe
; 41(Suppl 2): 138-142, 2020 Dec.
Article
in German
| MEDLINE | ID: mdl-33263809
3.
RNA-based analysis of ALK fusions in non-small cell lung cancer cases showing IHC/FISH discordance.
BMC Cancer
; 18(1): 1158, 2018 Nov 22.
Article
in English
| MEDLINE | ID: mdl-30466405
4.
Mutational analysis of pulmonary tumours with neuroendocrine features using targeted massive parallel sequencing: a comparison of a neglected tumour group.
Br J Cancer
; 113(12): 1704-11, 2015 Dec 22.
Article
in English
| MEDLINE | ID: mdl-26645239
5.
SOX4, SOX11 and PAX6 mRNA expression was identified as a (prognostic) marker for the aggressiveness of neuroendocrine tumors of the lung by using next-generation expression analysis (NanoString).
Future Oncol
; 11(7): 1027-36, 2015.
Article
in English
| MEDLINE | ID: mdl-25804118
6.
Different micro-RNA expression profiles distinguish subtypes of neuroendocrine tumors of the lung: results of a profiling study.
Mod Pathol
; 27(12): 1632-40, 2014 Dec.
Article
in English
| MEDLINE | ID: mdl-24875640
7.
Mdm2 protein expression is strongly associated with survival in malignant pleural mesothelioma.
Future Oncol
; 10(6): 995-1005, 2014 May.
Article
in English
| MEDLINE | ID: mdl-24941985
8.
Quality-Assured Analysis of PIK3CA Mutations in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Tissue: A Story About the Need for Proficiency Testing for High-Quality Molecular Biomarker Reporting in Precision Medicine.
J Mol Diagn
; 2024 Apr 30.
Article
in English
| MEDLINE | ID: mdl-38697471
9.
High Concordance of Different Assays in the Determination of Homologous Recombination Deficiency-Associated Genomic Instability in Ovarian Cancer.
JCO Precis Oncol
; 8: e2300348, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38513168
10.
cCPE Fusion Proteins as Molecular Probes to Detect Claudins and Tight Junction Dysregulation in Gastrointestinal Cell Lines, Tissue Explants and Patient-Derived Organoids.
Pharmaceutics
; 15(7)2023 Jul 19.
Article
in English
| MEDLINE | ID: mdl-37514167
11.
Proficiency testing of PIK3CA mutations in HR+/HER2-breast cancer on liquid biopsy and tissue.
Virchows Arch
; 482(4): 697-706, 2023 Apr.
Article
in English
| MEDLINE | ID: mdl-36367572
12.
Development of the NOGGO GIS v1 Assay, a Comprehensive Hybrid-Capture-Based NGS Assay for Therapeutic Stratification of Homologous Repair Deficiency Driven Tumors and Clinical Validation.
Cancers (Basel)
; 15(13)2023 Jun 30.
Article
in English
| MEDLINE | ID: mdl-37444554
13.
Comparative investigation of cell cycle and immunomodulatory genes in mucosal and cutaneous melanomas: Preliminary data suggest a potential promising clinical role for p16 and the PD-1/PD-L1 axis.
Pathol Res Pract
; 229: 153689, 2022 Jan.
Article
in English
| MEDLINE | ID: mdl-34844086
14.
Liquid Biopsy in Colorectal Cancer: Quo Vadis? Implementation of Liquid Biopsies in Routine Clinical Patient Care in Two German Comprehensive Cancer Centers.
Front Oncol
; 12: 870411, 2022.
Article
in English
| MEDLINE | ID: mdl-35646657
15.
DNA methylation-based classification of sinonasal tumors.
Nat Commun
; 13(1): 7148, 2022 11 28.
Article
in English
| MEDLINE | ID: mdl-36443295
16.
NeoRAS wild-type in metastatic colorectal cancer: Myth or truth?-Case series and review of the literature.
Eur J Cancer
; 153: 86-95, 2021 08.
Article
in English
| MEDLINE | ID: mdl-34153718
17.
Pembrolizumab as First-Line Palliative Therapy in PD-L1 Overexpressing (≥ 50%) NSCLC: Real-world Results with Special Focus on PS ≥ 2, Brain Metastases, and Steroids.
Clin Lung Cancer
; 22(5): 411-422, 2021 09.
Article
in English
| MEDLINE | ID: mdl-33648877
18.
KRASG12C/TP53 co-mutations identify long-term responders to first line palliative treatment with pembrolizumab monotherapy in PD-L1 high (≥50%) lung adenocarcinoma.
Transl Lung Cancer Res
; 10(2): 737-752, 2021 Feb.
Article
in English
| MEDLINE | ID: mdl-33718018
19.
Status quo of ALK testing in lung cancer: results of an EQA scheme based on in-situ hybridization, immunohistochemistry, and RNA/DNA sequencing.
Virchows Arch
; 479(2): 247-255, 2021 Aug.
Article
in English
| MEDLINE | ID: mdl-34173019
20.
Validation of a Targeted Next-Generation Sequencing Panel for Tumor Mutation Burden Analysis: Results from the Onconetwork Immuno-Oncology Consortium.
J Mol Diagn
; 23(7): 882-893, 2021 07.
Article
in English
| MEDLINE | ID: mdl-33964449